At our U CAN-CER VIVE Dreamy Evening for the Cure on Friday, June 2, 2023 we honored and recognized individuals who are making a difference and an impact in our community and in the world of cancer.
We can’t thank our sponsors, donors, volunteers and supporters enough for their unwavering support. We are proud to announce that we raised over $500,000 towards vital funds for cancer research. What’s even more amazing is that 100% of profits raised to our cause! We couldn’t do it without your support, so thank you from the bottom of our hearts.
During this magical evening, we took a special moment to honor two individuals who are making strides in the cancer community. One of which includes a hospital partner who has poured her heart and passion into her work and into our community. Linda Filipczak from Barbara Ann Karmanos Cancer Institute has been making strides in the cancer community, along with helping U CAN-CER VIVE to fulfill our mission. We have been proud to support the research at Karmanos, and Linda has been a helping hand along the way! During our Evening for the Cure program, we honored Linda with our Community Partner Award for 2023. She is so deserving!
As a committee, we aim to lead with our hearts, inspire one another, and spread the word about cancer research within our community. As a partner with C.S. Mott Children’s Hospital and Michigan Medicine, Davis Warren, a football player and student at Michigan University, was kindly introduced to us in early 2023. We realized how powerful and meaningful the connection was when Davis shared his story of battling Leukemia during his high school football years…
If you can’t find him on the field, you can find him volunteering his time bringing awareness to the same thing we are all supporting; cancer research funding. We are so proud to share that Davis Warren will be our 2023-2024 U CAN-CER VIVE Ambassador! We look forward to sharing his journey with you all and feel honored to have Davis represent for himself, the cancer community, and for our foundation.
